# Prevention of Nosocomial Infection by Decontamination of the Naso- and Oropharynx With Chlorhexidine (NONI Trial)

> **NCT00272675** · PHASE2,PHASE3 · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 1000 (—)

## Conditions studied

- Nosocomial Infection
- Respiratory Tract Infection
- Surgical Site Infection

## Interventions

- **DRUG:** Chlorhexidine gluconate (drug) vs placebo

## Key facts

- **NCT ID:** NCT00272675
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 1000 (—)
- **Last updated:** 2006-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00272675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00272675, "Prevention of Nosocomial Infection by Decontamination of the Naso- and Oropharynx With Chlorhexidine (NONI Trial)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00272675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*